While they blame PBMs for the high price of insulin, insulin makers pocket 47% of the price, an 8 times increase from the 1990s.

The cost of insulin in the U.S. is almost 7 times more expensive than the next country.

Since 1996, insulin manufacturers have increased the price of a vial of insulin in the United States by almost 1200%.

The United States accounts for just 6% of the world’s diabetics, but 39.3% of the healthcare costs.

U.S. House of Representatives Committee on Oversight and Reform investigated pharma abuses of the healthcare system to increase profits at the expense of patients.